Long‐term outcome after breast‐conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast
Top Cited Papers
Open Access
- 26 January 2005
- Vol. 103 (6) , 1137-1146
- https://doi.org/10.1002/cncr.20886
Abstract
BACKGROUND Ductal carcinoma in situ (DCIS) is detected most commonly on routine screening mammography in the asymptomatic patient, and has a long natural history. The objective of the current study was to determine the long‐term outcome after breast‐conservation surgery followed by definitive breast irradiation for women with mammographically detected DCIS of the breast. METHODS In total, 1003 women with unilateral, mammographically detected DCIS of the breast underwent breast‐conserving surgery followed by definitive breast irradiation. These women were treated in 10 institutions in North America and Europe. The median follow‐up was 8.5 years (mean, 9.0 years; range, 0.2–24.6 years). RESULTS The 15‐year overall survival rate was 89%, and the 15‐year cause‐specific survival rate was 98%. The 15‐year rate of freedom from distant metastases was 97%. In total, there were 100 local failures (10%) in the treated breast. The 15‐year rate of any local failure was 19%, and the 15‐year rate of local only first failure was 16%. Patient age ≥ 50 years at the time of treatment and negative final pathology margins from the primary tumor excision both were associated independently with a lower risk of local failure in univariate analysis (P = 0.00062 and P = 0.024, respectively) and in multivariate analysis (P = 0.00057 and P = 0.0026, respectively). For favorable subgroups of patients age ≥ 50 years or with negative resection margins, the 10‐year risk of local failure was ≤ 8%. CONCLUSIONS The current results support the use of breast‐conserving surgery followed by definitive breast irradiation for the treatment of patients with mammographically detected DCIS of the breast. Patient age ≥ 50 years at the time of treatment and negative resection margins both were associated independently with a decreased risk of local failure. Cancer 2005. © 2005 American Cancer Society.Keywords
This publication has 43 references indexed in Scilit:
- Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyCancer, 2006
- Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experienceSeminars in Oncology, 2001
- Intraductal Carcinoma of the BreastThe American Journal of Surgical Pathology, 2000
- The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the BreastNew England Journal of Medicine, 1999
- Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Intraductal carcinoma of the breast: Long-term results with breast-conserving surgery and definitive irradiationEuropean Journal Of Cancer, 1993
- Breast conservation therapy for intraductal carcinoma of the breastInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breastThe American Journal of Surgery, 1990
- The role of limited surgery with irradiation in primary treatment of ductal in situ breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvageInternational Journal of Radiation Oncology*Biology*Physics, 1985